Abstract：
OBJECTIVE: To evaluate the availability of mifepristone and misoprostol at pharmacies in a state with protective abortion legislation and variation in access by rurality.
METHODS: Using a secret shopper survey, researchers attempted to contact all community pharmacies in Oregon and evaluate their mifepristone and misoprostol provisions.
RESULTS: Among the 444 pharmacies surveyed, mifepristone was planned at 19.2%. Misoprostol was available at 77.5%, but stocking issues and medication ordering impact access, without significant differences by rurality.
CONCLUSIONS: Pharmacy engagement and support are key to increasing access to these essential medicines, which may be improved through education and referral programs.
METHODS: Using a secret shopper survey, researchers attempted to contact all community pharmacies in Oregon and evaluate their mifepristone and misoprostol provisions.
RESULTS: Among the 444 pharmacies surveyed, mifepristone was planned at 19.2%. Misoprostol was available at 77.5%, but stocking issues and medication ordering impact access, without significant differences by rurality.
CONCLUSIONS: Pharmacy engagement and support are key to increasing access to these essential medicines, which may be improved through education and referral programs.
摘要：
目的：评估在有保护性流产立法的州的药房中，米非司酮和米索前列醇的可获得性，并通过乡村获得。
方法：使用秘密购物者调查，研究人员试图联系俄勒冈州的所有社区药房,并评估他们的米非司酮和米索前列醇供应.
结果：在接受调查的444家药店中，米非司酮计划为19.2%。米索前列醇为77.5%，但是库存问题和药物订购会影响获取，农村没有显著差异。
结论：药房的参与和支持是增加获得这些基本药物的关键，可以通过教育和转介计划来改善。
方法：使用秘密购物者调查，研究人员试图联系俄勒冈州的所有社区药房,并评估他们的米非司酮和米索前列醇供应.
结果：在接受调查的444家药店中，米非司酮计划为19.2%。米索前列醇为77.5%，但是库存问题和药物订购会影响获取，农村没有显著差异。
结论：药房的参与和支持是增加获得这些基本药物的关键，可以通过教育和转介计划来改善。
